KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Tax Provisions: 2019-2025

Historic Tax Provisions for Aurinia Pharmaceuticals (AUPH) over the last 6 years, with Sep 2025 value amounting to $411,000.

  • Aurinia Pharmaceuticals' Tax Provisions fell 17.80% to $411,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 30.72%. This contributed to the annual value of $1.7 million for FY2024, which is 183.33% up from last year.
  • According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Tax Provisions is $411,000, which was down 36.08% from $643,000 recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Tax Provisions registered a high of $1.0 million during Q1 2025, and its lowest value of -$642,000 during Q2 2023.
  • Its 3-year average for Tax Provisions is $399,273, with a median of $500,000 in 2024.
  • In the last 5 years, Aurinia Pharmaceuticals' Tax Provisions spiked by 11,825.00% in 2022 and then plummeted by 7,233.33% in 2023.
  • Aurinia Pharmaceuticals' Tax Provisions (Quarterly) stood at $726,000 in 2021, then increased by 17.77% to $855,000 in 2022, then crashed by 41.52% to $500,000 in 2023, then tumbled by 160.00% to -$300,000 in 2024, then declined by 17.80% to $411,000 in 2025.
  • Its last three reported values are $411,000 in Q3 2025, $643,000 for Q2 2025, and $1.0 million during Q1 2025.